Autolomous aims to provide digital solutions to Centers for Breakthrough Medicines to streamline and automate cell and gene therapy manufacturing
The US Center for Breakthrough Medicines (CBM), a Cell and Gene Therapy Contract Organization for Development, Manufacturing, and Testing, has entered into a licencing agreement with Autolomous LTD, the market-leading developer of critical manufacturing management systems for cell and gene…